Inhibrx Biosciences INBX
NASDAQ INBX
$95.08 -3.11 (-3.17%)
As of: Oct 22, 2026 · 3:20 PM EDT

Inhibrx Biosciences (INBX) Revenue (2023 - 2025)

Updated

Inhibrx Biosciences' Revenue was $1.3 million in FY2025, up 550.0% from $200,000 in FY2024.

Analysis

Inhibrx Biosciences (INBX) Revenue (2023 - 2025) Analysis & Trends

  • Per Business Quant data, Revenue in earlier years was $200,000 in FY2024 (-88.9%) and $1.8 million in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Eli Lilly 1,169.70 Bn 1,138.29 Bn 19.71 Bn 22.97 Bn
2 Johnson & Johnson 647.50 Bn 567.36 Bn 17.30 Bn 25.40 Bn
3 AbbVie 504.26 Bn 477.37 Bn 12.70 Bn 16.99 Bn
4 Merck 368.38 Bn 322.75 Bn 12.21 Bn 16.61 Bn
5 Novartis Ag 303.14 Bn 267.13 Bn 11.24 Bn 14.41 Bn
6 Astrazeneca 268.24 Bn 241.93 Bn 12.86 Bn 15.38 Bn
7 Amgen 242.50 Bn 197.90 Bn 7.24 Bn 10.05 Bn
8 Gilead Sciences 194.79 Bn 168.99 Bn 6.22 Bn 7.80 Bn
9 Pfizer 173.14 Bn 119.78 Bn 10.94 Bn 15.03 Bn
10 Inhibrx Biosciences 1.49 Bn 892.55 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 1.30 Mn
Dec 31, 2024 100,000.00
Jun 30, 2024 100,000.00
Dec 31, 2023 1.63 Mn
Sep 30, 2023 119,000.00
Jun 30, 2023 30,000.00
API Access

Inhibrx Biosciences Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=INBX&period=max&api_key=YOUR_API_KEY